BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hoshimoto A, Tatsuguchi A, Hamakubo R, Nishimoto T, Omori J, Akimoto N, Tanaka S, Fujimori S, Hatori T, Shimizu A, Iwakiri K. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment. World J Gastroenterol 2023; 29(40): 5566-5581 [PMID: 37970475 DOI: 10.3748/wjg.v29.i40.5566]
URL: https://www.wjgnet.com/1948-5204/full/v29/i40/5566.htm
Number Citing Articles
Mohamed Wishahi. Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent conceptWorld Journal of Hepatology 2024; 16(4): 490-493 doi: 10.4254/wjh.v16.i4.490
Grigorios Christodoulidis, Marina Nektaria Kouliou, Konstantinos Eleftherios Koumarelas. Immune signature of small bowel adenocarcinoma and the role of tumor microenvironmentWorld Journal of Gastroenterology 2024; 30(8): 794-798 doi: 10.3748/wjg.v30.i8.794